Strs Ohio Abb Vie Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Abb Vie Inc. stock. As of the latest transaction made, Strs Ohio holds 797,004 shares of ABBV stock, worth $135 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

797,004

Previous 818,885 2.67%

Holding current value

$135 Million

Previous $140 Million 12.06%

% of portfolio

0.62%

Previous 0.56%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$163.84 - $199.33 $3.58 Million - $4.36 Million	-21,881 Reduced 2.67%	797,004 $157 Million
Q2 2024 Aug 05, 2024	BUY	$154.79 - $180.76 $6.79 Million - $7.92 Million	43,837 Added 5.66%	818,885 $140 Million
Q1 2024 May 13, 2024	BUY	$159.82 - $182.1 $10.2 Million - $11.6 Million	63,609 Added 8.94%	775,048 $141 Million
Q4 2023 Jan 30, 2024	SELL	$137.6 - $154.97 $3.83 Million - $4.32 Million	-27,846 Reduced 3.77%	711,439 $110 Million
Q3 2023 Oct 26, 2023	SELL	$133.59 - $154.65 $794,994 - $920,322	-5,951 Reduced 0.8%	739,285 $110 Million
Q2 2023 Jul 31, 2023	BUY	$132.51 - $164.9 $191,079 - $237,785	1,442 Added 0.19%	745,236 $100 Million
Q1 2023 Aug 02, 2023	SELL	$144.61 - $166.54 $208,527 - $240,150	-1,442 Reduced 0.19%	743,794 $119 Million
Q1 2023 Apr 27, 2023	SELL	$144.61 - $166.54 $3.94 Million - $4.53 Million	-27,226 Reduced 3.53%	743,794 $119 Million
Q4 2022 Jan 26, 2023	SELL	$138.31 - $165.87 $3.6 Million - $4.31 Million	-26,003 Reduced 3.26%	771,020 $125 Million
Q3 2022 Oct 27, 2022	SELL	$134.21 - $153.93 $5.68 Million - $6.51 Million	-42,290 Reduced 5.04%	797,023 $107 Million
Q2 2022 Jul 25, 2022	SELL	$137.62 - $174.96 $25 Million - $31.8 Million	-181,700 Reduced 17.8%	839,313 $129 Million
Q1 2022 Apr 21, 2022	SELL	$131.98 - $163.75 $8.78 Million - $10.9 Million	-66,520 Reduced 6.12%	1,021,013 $166 Million
Q4 2021 Jan 24, 2022	SELL	$107.43 - $135.93 $5.05 Million - $6.4 Million	-47,051 Reduced 4.15%	1,087,533 $147 Million
Q3 2021 Oct 22, 2021	SELL	$106.4 - $120.78 $4.66 Million - $5.29 Million	-43,766 Reduced 3.71%	1,134,584 $122 Million
Q2 2021 Jul 26, 2021	SELL	$105.21 - $117.21 $10.4 Million - $11.6 Million	-99,284 Reduced 7.77%	1,178,350 $133 Million
Q1 2021 Apr 23, 2021	SELL	$102.3 - $112.62 $7.38 Million - $8.13 Million	-72,178 Reduced 5.35%	1,277,634 $138 Million
Q4 2020 Jan 25, 2021	BUY	$80.49 - $108.67 $4.06 Million - $5.48 Million	50,448 Added 3.88%	1,349,812 $145 Million
Q3 2020 Dec 14, 2020	SELL	$85.91 - $100.83 $2.57 Million - $3.02 Million	-29,918 Reduced 2.25%	1,299,364 $114 Million
Q2 2020 Jul 23, 2020	BUY	$73.37 - $98.18 $32.2 Million - $43 Million	438,380 Added 49.21%	1,329,282 $131 Million
Q1 2020 Apr 23, 2020	BUY	$64.5 - $97.79 $137,127 - $207,901	2,126 Added 0.24%	890,902 $67.9 Million
Q4 2019 Jan 24, 2020	SELL	$72.13 - $90.25 $3.36 Million - $4.21 Million	-46,618 Reduced 4.98%	888,776 $78.7 Million
Q3 2019 Oct 21, 2019	BUY	$62.98 - $75.72 $2.73 Million - $3.29 Million	43,420 Added 4.87%	935,394 $70.8 Million
Q2 2019 Jul 25, 2019	BUY	$65.7 - $83.98 $8.36 Million - $10.7 Million	127,227 Added 16.64%	891,974 $64.9 Million
Q1 2019 Apr 19, 2019	BUY	$77.14 - $90.79 $152,660 - $179,673	1,979 Added 0.26%	764,747 $61.6 Million
Q4 2018 Jan 23, 2019	BUY	$77.85 - $96.01 $126,739 - $156,304	1,628 Added 0.21%	762,768 $70.3 Million
Q3 2018 Oct 19, 2018	SELL	$88.91 - $98.84 $14 Million - $15.5 Million	-156,931 Reduced 17.09%	761,140 $72 Million
Q2 2018 Aug 06, 2018	SELL	$89.78 - $106.23 $3.02 Million - $3.57 Million	-33,617 Reduced 3.53%	918,071 $85.1 Million
Q1 2018 Apr 20, 2018	SELL	$92.01 - $123.21 $2.41 Million - $3.22 Million	-26,151 Reduced 2.67%	951,688 $90.1 Million
Q4 2017 Jan 23, 2018	SELL	$89.56 - $98.21 $1.74 Million - $1.91 Million	-19,403 Reduced 1.95%	977,839 $94.6 Million
Q3 2017 Oct 23, 2017	BUY	$69.85 - $89.22 $69.7 Million - $89 Million	997,242	997,242 $88.6 Million

Others Institutions Holding ABBV

# of Institutions

3,837

Shares Held

1.25B

Call Options Held

15.7M

Put Options Held

11.3M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $300B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account